XML 49 R26.htm IDEA: XBRL DOCUMENT v3.25.2
Debt (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Schdule of Convertible Debentures  
The following table provides a summary of the changes in the balance and the estimated fair value of the Convertible Debentures (in thousands):
 
    
December 31,
2024
 
Ending Balance as of December 31, 2023
   $ 4,340  
Repayment of Convertible Debentures
     (4,375
Change in fair value of Convertible Debentures
     35  
  
 
 
 
Ending Balance as of December 31, 2024
   $ —   
  
 
 
 
Schedule of the Oramed Note
The following table provides a summary of the changes in the balance and the estimated fair value of the Oramed Note (in thousands):
 
    
March 31,
2025
 
Ending Balance as of December 31, 2024
   $ 12,161  
Change in fair value of Oramed Note - recorded in the consolidated statements of operations
     2,801  
  
 
 
 
Ending Balance as of March 31, 2025
   $ 14,962  
  
 
 
 
 
Schedule of FSF Deposit  
The following table provides a summary of the changes in the balance and the estimated fair value of the FSF Deposit (in thousands):
 
    
December 31,
2024
 
Beginning Balance as of June 11, 2024
   $ 10,000  
Change in fair value of FSF Deposit
     4,690  
Reclass of Deposit Warrant liability upon satisfaction of FSF Deposit
     (1,690
Repayment of FSF Deposit
     (13,000
  
 
 
 
Ending Balance as of December 31, 2024
   $ —   
  
 
 
 
Schedule of revenue liability activity
The following table summarizes the purchased revenue liability activity related to ZTlido Royalty Purchase Agreement during the three months ended March 31, 2025 (in thousands):
 
    
March 31,
2025
 
Ending Balance as of December 31, 2024
   $ 6,800  
Repayment of purchased revenue liability
     (797
Change in fair value of purchased revenue liability
     797  
  
 
 
 
Ending Balance as of March 31, 2025
   $ 6,800  
  
 
 
 
The following table summarizes the purchased revenue liability activity during the year ended December 31, 2024 (in thousands):
 
    
December 31,
2024
 
Beginning Balance as of October 8, 2024
   $ 5,900  
Change in fair value of purchased revenue liability
     900  
  
 
 
 
Ending Balance as of December 31, 2024
   $ 6,800  
  
 
 
 
Schedule of the Tranche B Note
The following table provides a summary of the changes in the balance and the estimated fair value of the Tranche B Notes (in thousands):
 
    
March 31,
2025
 
Ending Balance as of December 31, 2024
   $ 23,560  
Repayment of Tranche B Notes principal and interest
     (1,596
Change in fair value of Tranche B Notes
     2,516  
  
 
 
 
Ending Balance as of March 31, 2025
   $ 24,480  
  
 
 
 
 
Oramed Note    
Debt Instrument [Line Items]    
Schedule of the Oramed Note  
 
    
December 31,
2024
 
Ending Balance as of December 31, 2023
   $ 104,089  
Repayment of Oramed Note
     (64,200
Conversion into Tranche B Notes
     (25,000
Change in fair value of Oramed Note – recorded in the consolidated statements of operations
     3,589  
Change in fair value of Oramed Note – due to instrument-specific credit risk recorded as a component of other comprehensive income
     (6,317
  
 
 
 
Ending Balance as of December 31, 2024
   $ 12,161  
  
 
 
 
Tranche B Notes [Member]    
Debt Instrument [Line Items]    
Schedule of Tranche B Notes  
The following table provides a summary of the changes in the balance and the estimated fair value of the Tranche B Notes (in thousands):
 
    
December 31,
2024
 
Beginning Balance as of October 8, 2024
   $ 42,740  
Conversion of Tranche B notes
     (9,255
Repayment of Tranche B Notes
     (3,283
Change in fair value of Tranche B Notes
     (6,641
  
 
 
 
Ending Balance as of December 31, 2024
   $ 23,560